Abstract:Purpose: A prospective randomized clinical trial was conducted to compare the effect of late course accelerated hyperfractionation(LCAHF) with that of conventional fractionation(CF) in the treatment of nasopharyngeal carcinoma(NPC).This study tried to improve the local control by treating the parients with LCAHF radiotherapy.Methods and Materials:156 patients histologically proven nasopharyngeal squamous cell carcinoma were staged,according to ′92 stage classification,to be T1-4N0-2M0 and 154 of them were randomized into CF group(n=80)or LCAHF group(n=74).The 154 patients were evaluable for analysis.The median follow-up time was 38 months(range:22～65) months).The doses of CF group to primary lesion were 6 964～7 803 cGy in 37～42 fractions with 180～190 cGy per fraction daily over 50～63 days. The radiotherapy of LCAHF was divided into two phases:About 4 000 cGy with 180～196 cGy per fraction daily,5 days weekly in the first phase,followed by 150cGy per fraction,twice daily to the total doses of 6 923～8 015 cGy in 41～47 fractions over 42～54 days.The median dose to cervical lymph nodes metastasis was 6 564 cGy in 37 fractions over 53 days.Results:At 3 months after radiotherapy,the complete response rate determined by clinical examination in CF group and LCAHF group were 98.8% and 100%,respectively while the residual mass of parapharyngeal region on CT scan was 43%(25/58)and 34%(17/50),respectively.9 cases in CF group had local failure and two cases did in LCAHF group.The 3-year free from local failure rate(FLF) was 88.5% in CF group vs 96% in LCAHF group(P=0.03).Three-year actuarial survival,disease free survival,and free from distant metastasis rates were 80%,67.22%,and 82.1%,respecrively in CF group and 88.6%,77.9%,and 76.8%,respecrively in LCAHF group,without any significant differences.Fractional regimen was demonstrated to be an independent prognostic tactor influencing local control using Cox regression model.The control rates of cervical lymph nodes were similar between these two groups.Acute toxicity was of similar magnitrde,althouhy the grade Ⅲ mucositis appeared more often in CF group.No difference in late toxicity was found between the groups.Conclusion: The late course accelerated hyperfractionation schedule can improve the local control in patients with NPC,compared with conventional fractionation.Further follow-up is needed to evaluate the effect of LCAHF scheme on long survival rate and late toxicity.

The Analyses of 81 Patients with Stage Ⅲ Non-Small Cell Lung Cancer Treated by Late Course Accelerated Hyperfractionation Radiotherapy

Late Course Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage Ⅲ Non-Small Cell Lung Cancer

Clinical Study on the Effect of Hypofractionated Three -Dimensional Conformal Radiation Therapy in the Treatment of Non -Small Cell Lung Cancer

Retrospective Analysis on Results of Late Course Accelerated Hyperfractionation Radiotherapy and Conventional Fractionation Radiotherapy Plus Brachytherapy for Esophageal Carcinoma

The Effect of Accelerated Hyperfractionation Versus Conventional Radiotherapy in Nasopharyngeal Carcinoma

Late Course Accelerated Hyperfractionation Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Feasibility and Efficacy of Helical Intensity-Modulated Radiotherapy for Stage III Non-Small Cell Lung Cancer in Comparison with Conventionally Fractionated 3D-CRT.

Late Course Accelerated Hyperfractionation Radiotherapy for Nasopharyngeal Carcinoma

Late Course Accelerated Hyperfractionation Radiotherapy for Esophageal Carcinoma

Analysis of Phase Ⅲ Randomized Trial of Conventional Irradiaton Versus Hyperfractionated Irradiation with Late Course Concomitant Boost in Nasopharyngeal Carcinoma

Three Dimensional-conformal Radiotherapy Combined Concurrent Chemotherapy with Vinorelbine and Cisplatin for Stage Ⅲ Non-small Cell Lung Cancer

Analysis of outcome and failure reasons of late course accelerated hyperfration ation radiotherapy for esophageal carcinoma

Clinical Study of Late-Course Three-Dimensional Conformal Radiotherapy for Esophageal Carcinoma

[Late Course Accelerated Hyper-Fractionated Radiotherapy of Upper and Middle Thoracic Esophageal T2N0M0 Carcinoma].

Late Course Accelerated Hyperfractionation Radiotherapy for Elderly Patients with Esophageal Carcinoma

A Phase Iii Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients with Nasopharyngeal Carcinoma

Meta-analysis of Late Course Accelerated Hyperfractionated Radiotherapy Combined with FP Chemotherapy for Esophageal Carcinoma

Randomized trial of hyperfractionated plus accelerated hyperfractionated radiation therapy with or without concomitant chemotherapy for stage III A / III B non-small-cell lung cancer: A preliminary result

Concurrent paclitaxel or/and carboplatin with radiotherapy for stageⅢnon-small cell lung cancer

Late Course Accelerated Hyperfractionated Radiotherapy Plus Concurrent Chemotherapy for Squamous Cell Carcinoma of the Esophagus: a Phase III Randomized Study.